Quintiles Celebrates 10 Years in India with Dedication of New Lab

Quintiles Celebrates 10 Years in India with Dedication of New Lab

April 09, 2007

Mumbai Facility Expands Suite of Services Offered for
Global Clinical Trials


    RESEARCH TRIANGLE PARK, N.C., April 9
/Xinhua-PRNewswire/ -- 

    Dennis Gillings, CBE, Chairman and CEO of Quintiles
Transnational Corp., today dedicated the company's new
central lab in Mumbai, India, and congratulated Quintiles
India for its 10 years of growth and leadership in clinical
research.

    The new lab expands Quintiles' global central
laboratory network and enhances the suite of services
offered in India to support global and regional clinical
trials.  In addition to its central lab and clinical
research businesses, Quintiles India offers
electrocardiogram (ECG), interactive voice response (IVR)
and data management services.

    "The opening of this new lab in India symbolizes
the rapid growth and achievement of our team here, as well
as the acceptance of India as a center for clinical
research," Gillings said.  "Since establishing an
office in Ahmedabad 10 years ago, we have added offices in
Mumbai and Bangalore with a full complement of services,
expanded our clinical research staff to 750 and have
conducted more than 700 global trials across business
lines.  We also were involved in the training of hundreds
of investigators on Good Clinical Practice guidelines and
helped put India on the world map for clinical
research."

    Ferzaan Engineer, CEO of Quintiles India, said,
"The rapid growth of Quintiles India has been the
result of hard work by a dedicated group of people who are
focused on meeting the highest standards for quality and
customer service.  That focus, in turn, has brought more
and more global customers to us, and the need to expand our
services, including this new central lab."

    Tom Wollman, Senior Vice President, Global Central
Laboratories, said the new lab is harmonized with
Quintiles' global network. "The India lab has begun
proficiency testing for certification by the College of
American Pathologists (CAP), and we look forward to adding
another lab with this well-recognized global standard of
quality to our global footprint."   

    The Mumbai lab will provide access to Quintiles
laboratory kits, ensure that all study samples are
processed using consistent methods and completed in a
timely manner, and will oversee the data transfer for
inclusion in the Quintiles Laboratory Information
Management System and the protocol-specific database.
    
    About Quintiles Laboratories

    Quintiles Laboratories owns a network of clinically
harmonized facilities in the U.S., Europe, South Africa,
India, China and Singapore, and has a tightly controlled
network of sub-contractor laboratories in Argentina and
Brazil managed by Quintiles employees located in each of
the sub-contractor facilities.

    About Quintiles

    Quintiles Transnational Corp. is powering the next
generation of healthcare by providing a broad range of
professional services in drug development, financial
partnering and commercialization for the biotechnology and
healthcare industries. With 17,000 employees and offices in
more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of
the industry. For more information, please visit the
company's Web site at http://www.quintiles.com .


    For more information, please contact:

     Dick Jones
     Media Relations
     Tel:   [phone]
     Email: [e-mail]

     Greg Connors
     Investor Relations
     Tel:   [phone]
     Email: [e-mail]